期刊
ERJ OPEN RESEARCH
卷 7, 期 4, 页码 -出版社
EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/23120541.00457-2021
关键词
-
资金
- European Respiratory Society (ERS)
- ERS
- AstraZeneca UK Ltd
- Chiesi Farmaceutici
- GlaxoSmithKline LLC
- Menarini
- Sanofi-Genzyme
This study investigated the prevalences of obstructive and restrictive spirometric phenotypes and their associations with respiratory risk factors in different age groups in European cohorts. Results suggest that early-life risk factors may be related to different spirometric phenotypes across ages.
Background The prevalences of obstructive and restrictive spirometric phenotypes, and their relation to early-life risk factors from childhood to young adulthood remain poorly understood. The aim was to explore these phenotypes and associations with well-known respiratory risk factors across ages and populations in European cohorts. Methods We studied 49 334 participants from 14 population-based cohorts in different age groups (410, >10-15, >15-20, >20-25 years, and overall, 5-25 years). The obstructive phenotype was defined as forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) z-score less than the lower limit of normal (LLN), whereas the restrictive phenotype was defined as FEV1/FVC z-score >= LLN, and FVC z-score
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据